Oxford’s COVID-19 Vaccine Candidate Takes a Big Leap Forward, Showing Success in Early Trials
Oxford's COVID-19 Vaccine Candidate Takes a Big Leap Forward, Showing Success in Early Trialshe foot race to develop the first effective vaccine against COVID-19 involves an awfully crowded field, with 137 candidate vaccines in pre-clinical study worldwide and another 23 actually in development. But a leader seemed to emerge today with researchreporting promising results in a robust study by investigators at Oxford University in England.
The vaccine uses a harmless-to-humans chimpanzee adenovirus as a delivery vector. That virus is modified to carry spike proteins from SARS-CoV-2—the component of the coronavirus that, in theory, should induce the sought-after immune response in humans.
“We are seeing good immune responses in almost everybody,” Dr. Adrian Hill, a professor of human genetics at Oxford University and one of the researchers on this particular study, told the Associated Press. “What this vaccine does particularly well is trigger both arms of the immune system.”
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Oxford vaccine trial shows ‘double immunity’ against COVID-19Oxford University released the results of its phase 1 trial, and found the vaccine creates double immunity antibody cells. They are now ready to move forward with more aggressive testing, including clinical trials in the United States.
Read more »
Oxford University, AstraZeneca Covid-19 Vaccine Front-Runner Shows Promise in TrialsA leading coronavirus-vaccine candidate being developed by University of Oxford researchers and AstraZeneca showed positive results in early trials, according to published results, raising the prospect that a shot could be available by the end of this year.
Read more »
Over a million doses of Oxford/AstraZeneca COVID-19 vaccine possible by September - researcherEarly estimates of the production a million doses of the University of Oxford's experimental COVID-19 vaccine by September could be an underestimate depending on how quickly late-stage trials can be completed, a researcher said on Monday.
Read more »
First human trial of AstraZeneca COVID-19 vaccine shows promiseAstraZeneca&39;s experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday. The vaccine, called AZD1222 and being developed by AstraZeneca and scientists at Britain&39;s University of Oxford, did not prompt any
Read more »
UK says 'confident' Russia helped hackers target Covid-19 vaccineBritish Foreign Secretary Dominic Raab says he is 'absolutely confident' that Russia was behind vaccine hack attempt
Read more »
S&P 500 gains on COVID-19 vaccine, stimulus hopesThe S&P 500 edged higher on Monday as promising data across a range of COVID-19 vaccine candidates and hopes of more stimulus helped overcome fears around the extent of the economic damage from a surge in domestic infections.
Read more »